CBFA2T3 and neoplasm: For example, Cbfa2t3 was identified as downregulated in STHSC:MA9 versus progenitor-derived tumours (Fig. 3b), and in human AML, low expression of CBFA2T3 was associated with poor prognosis (Fig. 3c).